NCT06065241View on ClinicalTrials.gov

Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 22, 2023

Primary Completion Date

March 28, 2024

Study Completion Date

March 28, 2024

Conditions
AgingInflammation
Interventions
DIETARY_SUPPLEMENT

LLP-01

Participants in the experimental group will take 2 capsules daily containing 1,000mg of the formulation, LLP-01, for 60 days.

OTHER

Placebo

Participants in the placebo group will take 2 capsules daily containing rice flower and small amount of Curcuma Longa for 60 days.

Trial Locations (1)

92121

LL Prosper Inc., San Diego

All Listed Sponsors
lead

LL Prosper Inc.

INDUSTRY

NCT06065241 - Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals. | Biotech Hunter | Biotech Hunter